B-905

Benzodiazepine Internal Standard-3 solution

0.5-1.0 mg/mL in acetonitrile, ampule of 1.0 mL, certified reference material, Cerilliant^®

• EG-Nummer: 200-835-2
• UNSPSC-Code: 41116107
• NACRES: NA.24

Eigenschaften

• Qualität: certified reference material
• Qualitätsniveau: 300
• Form: liquid
• Leistungsmerkmale: SNAP-N-SPIKE^®/SNAP-N-SHOOT^®
• Zusammensetzung: 7-Aminoclonazepam-D₄, 0.5 mg/mL ; 7-Aminoflunitrazepam-D₇, 0.5 mg/mL ; α-Hydroxytriazolam-D₄, 1.0 mg/mL
• Verpackung: ampule of 1.0 mL
• Hersteller/Markenname: Cerilliant^®
• drug control: Narcotic Licence Schedule B (Switzerland)
• Konzentration: 0.5-1.0 mg/mL in acetonitrile
• Methode(n): gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• Anwendung(en): clinical testing
• Format: single component solution
• Lagertemp.: 2-8°C

Beschreibung

Allgemeine Beschreibung

A stable-labeled internal multi-component solution mix of routinely tested benzodiazepines 7-aminoclonazepam, 7-aminoflunitrazepam, and α-hydroxytriazolam. This internal standard mix is suitable for quantitation of benzodiazepine levels in urine, serum or plasma by LC/MS or GC/MS for urine drug testing, clinical toxicology or forensic analysis.

Rechtliche Hinweise

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

Snap-N-Shoot is a registered trademark of Cerilliant Corporation

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Analyt

7-Aminoclonazepam-d₄ .5 %
7-Aminoflunitrazepam-d₇ .5 mg/mL

Sicherheitshinweise

• Piktogramme: GHS02,GHS07
• Signalwort: Danger
• H-Sätze: H225,H302 + H312 + H332,H319
• P-Sätze: P210 - P280 - P301 + P312 - P303 + P361 + P353 - P304 + P340 + P312 - P305 + P351 + P338
• Gefahreneinstufungen: Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2
• Lagerklassenschlüssel: 3 - Flammable liquids
• WGK: WGK 2
• Flammpunkt (°F): 35.6 °F - closed cup
• Flammpunkt (°C): 2 °C - closed cup